A global alliance for people affected by amyloidosis

Working for a future without amyloidosis.

A global alliance of patient organizations working with healthcare professionals, researchers and partners to improve diagnosis, care, research and the lives of people affected by amyloidosis.

24

member
organizations

worldwide

1

Global Mission

8

Languages

19

Countries

24

Member Organizations

al-attr-meeting-2027-london

22-24

Sept 2027

for patients and doctors

Register to the 6th international ATTR and AL Amyloidosis meeting

Patients and the specialists who treat them rarely share the same room. Scientific congresses are built for clinicians and researchers; patient meetings seldom give access to the teams working on the disease. The questions that weigh most in daily life, what to expect, what to watch for, what research is actually changing, are the ones that get the least time.

The International AL / ATTR Meeting for Patients and Doctors was created to close that distance. Since 2017, five editions have brought researchers, clinicians and patient organisations onto the same programme, in language everyone in the audience can follow. The sixth edition, in London in September 2027, is the first to bring the AL and ATTR communities together in a single international event.

The programme, the venue and the registration details will be announced as they are confirmed, on the meeting website.

Our Strategic Roadmap

Our Missions

A strategic roadmap for global healthcare transformation and patient empowerment.

About the Alliance

Discover the Amyloidosis Alliance

Discover the people, partnerships, and shared mission behind the Amyloidosis Alliance, and how together we are building a stronger future for patients worldwide.

Across Borders

An international network

With member organizations in 19 countries, the Alliance brings together local experience and expertise within a global network. Each member organization brings local knowledge and experience, helping the Alliance address shared challenges across countries and healthcare systems.

Illustrated globe

Our member
organizations are
spread across

19

countries

“By connecting patient organizations across borders, we can share experience, strengthen advocacy and reduce isolation.”

The Amyloidosis Alliance

Clinical Foundation

Understanding Amyloidosis

Pathology · Critical Data · Visualization

The Pathology

Protein Misfolding

Amyloidosis is a rare disease that occurs when an abnormal protein, called amyloid, builds up in organs and interferes with their normal function. Over thirty distinct subtypes exist, each requiring its own diagnostic pathway.

Diagnostic delay

4+

years

The average time to diagnosis. Our mission is to reduce this to months through global standard protocols.

Scientific Visualization

Amyloid fibril structure

30+

types of amyloidosis

More than 30 different types of amyloidosis have been identified, each associated with a specific amyloid-forming protein.

A world map drawn by a crowd of people seen from above

26

October
Awareness Day

World Awareness Campaign

World Amyloidosis Day

Every year on October 26, World Amyloidosis Day brings together patients, caregivers, healthcare professionals, researchers, institutions, and patient organizations to raise awareness of this rare and complex disease.

The campaign highlights the need for faster diagnosis, better access to care, and a stronger international network.

Latest Updates

Latest News

View All News